Oncogenic Targeting of BRM Drives Malignancy Through C/EBPβ-dependent Induction of α5 Integrin

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2013 Jun 18

PMID 23770848

Citations 10

Authors

L Damiano

K M Stewart

N Cohet

J K Mouw

J N Lakins

J Debnath

D Reisman

J A Nickerson

A N Imbalzano

V M Weaver

Affiliations

Soon will be listed here.

Abstract

Integrin expression and activity are altered in tumors, and aberrant integrin signaling promotes malignancy. However, how integrins become altered in tumors remains poorly understood. We discovered that oncogenic activation of MEK signaling induces cell growth and survival, and promotes the malignant phenotype of mammary epithelial cells (MECs) by increasing α5 integrin expression. We determined that MEK activates c-Myc to reduce the transcription of the SWI/SNF chromatin remodeling enzyme Brahma (BRM). Our studies revealed that reduced BRM expression and/or activity drives the malignant behavior of MECs by epigenetically promoting C/EBPβ expression to directly induce α5 integrin transcription. Consistently, we could show that restoring BRM levels normalized the malignant behavior of transformed MECs in culture and in vivo by preventing C/EBPβ-dependent α5 integrin transcription. Our findings identify a novel mechanism whereby oncogenic signaling promotes malignant transformation by regulating transcription of a key chromatin remodeling molecule that regulates integrin-dependent stromal-epithelial interactions.

Citing Articles

A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31.

Barnekow E, Hasslow J, Liu W, Bryant P, Thutkawkorapin J, Wendt C Int J Mol Sci. 2023; 24(5).

PMID: 36901898 PMC: 10003706. DOI: 10.3390/ijms24054468.

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.

Guerrero-Martinez J, Reyes J Sci Rep. 2018; 8(1):2043.

PMID: 29391527 PMC: 5794756. DOI: 10.1038/s41598-018-20217-3.

α5β1-Integrin promotes tension-dependent mammary epithelial cell invasion by engaging the fibronectin synergy site.

Miroshnikova Y, Rozenberg G, Cassereau L, Pickup M, Mouw J, Ou G Mol Biol Cell. 2017; 28(22):2958-2977.

PMID: 28877984 PMC: 5662256. DOI: 10.1091/mbc.E17-02-0126.

Hypoxia Selectively Enhances Integrin αβ Receptor Expression in Breast Cancer to Promote Metastasis.

Ju J, Godet I, Ye I, Byun J, Jayatilaka H, Lee S Mol Cancer Res. 2017; 15(6):723-734.

PMID: 28213554 PMC: 5510543. DOI: 10.1158/1541-7786.MCR-16-0338.

BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.

Liu G, Cuffe S, Liang S, Azad A, Cheng L, Brhane Y Clin Cancer Res. 2016; 23(10):2460-2470.

PMID: 27827316 PMC: 5422138. DOI: 10.1158/1078-0432.CCR-16-1640.

References

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Pylayeva Y, Gillen K, Gerald W, Beggs H, Reichardt L, Giancotti F . Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest. 2009; 119(2):252-66. PMC: 2631302. DOI: 10.1172/JCI37160. View

Zahnow C, Younes P, Laucirica R, Rosen J . Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J Natl Cancer Inst. 1997; 89(24):1887-91. DOI: 10.1093/jnci/89.24.1887. View

Bock V, Lyons J, Huang X, Jones A, McDonald L, Scolyer R . BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. Br J Dermatol. 2011; 164(6):1221-7. DOI: 10.1111/j.1365-2133.2011.10267.x. View

Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani T, Watanabe H . Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res. 2007; 67(22):10727-35. DOI: 10.1158/0008-5472.CAN-07-2601. View

Corbi A, Jensen U, Watt F . The alpha2 and alpha5 integrin genes: identification of transcription factors that regulate promoter activity in epidermal keratinocytes. FEBS Lett. 2000; 474(2-3):201-7. DOI: 10.1016/s0014-5793(00)01591-x. View

Paszek M, Zahir N, Johnson K, Lakins J, Rozenberg G, Gefen A . Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005; 8(3):241-54. DOI: 10.1016/j.ccr.2005.08.010. View

Khavari P, Peterson C, Tamkun J, Mendel D, Crabtree G . BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature. 1993; 366(6451):170-4. DOI: 10.1038/366170a0. View

Cohet N, Stewart K, Mudhasani R, Asirvatham A, Mallappa C, Imbalzano K . SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells. J Cell Physiol. 2010; 223(3):667-78. PMC: 3320666. DOI: 10.1002/jcp.22072. View

10.

Yu M, Ting D, Stott S, Wittner B, Ozsolak F, Paul S . RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature. 2012; 487(7408):510-3. PMC: 3408856. DOI: 10.1038/nature11217. View

11.

Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

12.

White D, Kurpios N, Zuo D, Hassell J, Blaess S, Mueller U . Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 2004; 6(2):159-70. DOI: 10.1016/j.ccr.2004.06.025. View

13.

Maschler S, Wirl G, Spring H, Bredow D, Sordat I, Beug H . Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene. 2005; 24(12):2032-41. DOI: 10.1038/sj.onc.1208423. View

14.

Gilbert P, Mouw J, Unger M, Lakins J, Gbegnon M, Clemmer V . HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J Clin Invest. 2010; 120(5):1535-50. PMC: 2860938. DOI: 10.1172/JCI39534. View

15.

Sun A, Tawfik O, Gayed B, Thrasher J, Hoestje S, Li C . Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate. 2006; 67(2):203-13. DOI: 10.1002/pros.20521. View

16.

Erez N, Truitt M, Olson P, Arron S, Hanahan D . Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell. 2010; 17(2):135-47. DOI: 10.1016/j.ccr.2009.12.041. View

17.

Williams C, Engler A, Slone R, Galante L, Schwarzbauer J . Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res. 2008; 68(9):3185-92. PMC: 2748963. DOI: 10.1158/0008-5472.CAN-07-2673. View

18.

Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T . Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci U S A. 1993; 90(6):2207-11. PMC: 46055. DOI: 10.1073/pnas.90.6.2207. View

19.

Haenssen K, Caldwell S, Shahriari K, Jackson S, Whelan K, Klein-Szanto A . ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J Cell Sci. 2010; 123(Pt 8):1373-82. PMC: 3705932. DOI: 10.1242/jcs.050906. View

20.

Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff R, McLean G, Frame M . Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc Natl Acad Sci U S A. 2007; 104(51):20302-7. PMC: 2154426. DOI: 10.1073/pnas.0710091104. View